.@ChuckGrassley and @SenBillCassidy: PDPRA makes important changes to the structure of the Part D program. Pharmacy Benefit Managers (PBMs), used by Part D drug plans, should be incentivized to control costs for patients.https://www.nationalreview.com/2019/10/prescription-drug-pricing-reduction-act-bipartisan-plan-make-prescription-drugs-affordable/ …
.@ChuckGrassley and @SenBillCassidy: But under the current system, when the cost of a medication rises above what is called the catastrophic level, the patient remains liable for 5 percent of the list price and the taxpayers for 80 percent.
-
-
.
@SenFinance Chairman@ChuckGrassley and@SenBillCassidy: PDPRA ends this negative incentive by changing how the Part D program is structured, so PBMs have more incentive to negotiate the best deal.Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.